User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Research update for articles published in EJCI in 2010

Primary tabs

Adlbrecht, Christopher Aigner, Elmar Bellón, Juan M. Bouloukaki, Izolde Bouzas-Mosquera, Alberto Starkel, Peter [UCL] Yilmaz, Yusuf

Research update for articles published in EJCI in 2010

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2012
Language Anglais
Journal information "European Journal of Clinical Investigation" - Vol. 42, no. 11, p. 1149-1164 (2012)
Peer reviewed yes
Publisher Wiley-Blackwell Publishing Ltd.
e-issn 1365-2362
issn 0014-2972
Publication status Publié
Affiliation UCL - SSS/IREC - Institut de recherche expérimentale et clinique
Links
  1. Stojakovic T., de Campo A., Scharnagl H., Sourij H., Schmölzer I., Wascher T. C., März W., Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events, 10.1111/j.1365-2362.2009.02249.x
  2. Winkler Karl, Jacob Stephan, Müller-Schewe Tina, Hoffmann Michael M., Konrad Thomas, Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus, 10.1016/j.atherosclerosis.2011.10.043
  3. Florentin Matilda, Liberopoulos Evangelos N., Moutzouri Elisavet, Rizos Christos V., Tselepis Alexandros D., Elisaf Moses S., The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia, 10.1185/03007995.2010.546394
  4. Berneis K., Rizzo M., Berthold H. K., Spinas G. A., Krone W., Gouni-Berthold I., Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial, 10.1093/eurheartj/ehq181
  5. Bays Harold, Conard Scott, Leiter Lawrence A, Bird Steven, Jensen Erin, Hanson Mary E, Shah Arvind, Tershakovec Andrew M, Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?, 10.1186/1476-511x-9-136
  6. Nair S., Nadkarni A., Warang P., Bhave A., Ghosh K., Colah R., Five α globin chain variants identified during screening for haemoglobinopathies, 10.1111/j.1365-2362.2009.02252.x
  7. Upadhye Dipti S, Jain Dipty, Nair Sona B, Nadkarni Anita H, Ghosh Kanjaksha, Colah Roshan B, First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders, 10.1136/jclinpath-2011-200642
  8. Chopra Anita, Fisher Chris, Khunger Jitender Mohan, Pati Haraprasad, Hemoglobin OIndonesia in India: a rare observation, 10.1007/s00277-010-1010-5
  9. Sharma Anjali, Marwah Sadhna, Buxi Gurdeep, Yadav RajBala, Falsely low HbA1c value due to a rare hemoglobin variant (HEMOGLOBIN J-MEERUT) - A family study, 10.4103/0377-4929.97912
  10. Warang Prashant, Nair Sona, Nadkarni Anita, Ghosh Kanjaksha, Colah Roshan B., Hb H Disease Due to Homozygosity for a Rare α2-Globin Variant, Hb Sallanches, 10.3109/03630260903547526
  11. Nadkarni Anita H., Nair Sona B., Italia Khushnooma Y., Warang Prashant, Dalvi Madhura, Ghosh Kanjaksha, Colah Roshan B., Molecular Diversity of Hemoglobin H Disease in India: Table 1, 10.1309/ajcp70orbrurvsjm
  12. Sun Ying, Eichelbaum Ehrentraud J., Lenz Anne, Wang Hai, Vesely David L., Epidermal growth factor’s activation of Ras is inhibited by four cardiac hormones, 10.1111/j.1365-2362.2010.02283.x
  13. Sun, Anticancer Res, 29, 971 (2009)
  14. Sun, Anticancer Res, 29, 1889 (2009)
  15. Sun, Cancer Ther, 7, 367 (2009)
  16. McGrath M. F., Ogawa T., de Bold A. J., Ras dexamethasone-induced protein 1 is a modulator of hormone secretion in the volume overloaded heart, 10.1152/ajpheart.01085.2011
  17. Lenz A., Sun Y., Eichelbaum E. J., Skelton W. P., Pi G., Vesely D. L., Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice, 10.1111/j.1365-2362.2010.02262.x
  18. Eichelbaum E.J., Sun Y., Alli A.A., Gower W.R., Vesely D.L., Cardiac and kidney hormones cure up to 86 of human small-cell lung cancers in mice, 10.1111/j.1365-2362.2008.01978.x
  19. Fujimori Shunji, Gudis Katya, Takahashi Yoko, Seo Tsuguhiko, Yamada Yukie, Ehara Akihito, Kobayashi Tsuyoshi, Mitsui Keigo, Yonezawa Masaoki, Tanaka Shu, Tatsuguchi Atsushi, Sakamoto Choitsu, Distribution of small intestinal mucosal injuries as a result of NSAID administration : DISTRIBUTION OF SMALL BOWEL NSAID INJURIES, 10.1111/j.1365-2362.2010.02290.x
  20. Wallace John L., Syer Stephanie, Denou Emmanuel, de Palma Giada, Vong Linda, McKnight Webb, Jury Jennifer, Bolla Manlio, Bercik Premysl, Collins Stephen M., Verdu Elena, Ongini Ennio, Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis, 10.1053/j.gastro.2011.06.075
  21. Hao, Methods Mol Biol, 268, 491 (2004)
  22. Adlbrecht C., Distelmaier K., Bonderman D., Beran G., Redwan B., Strunk G., Binder T., Jakowitsch J., Probst P., Heinze G., Maurer G., Lang I. M., Long-term outcome after thrombectomy in acute myocardial infarction, 10.1111/j.1365-2362.2009.02253.x
  23. Adlbrecht C., Distelmaier K., Gündüz D., Redwan B., Plass C., Bonderman D., Kaider A., Christ G., Lang I. M., Target vessel reopening by guidewire insertion in ST-elevation myocardial infarction is a predictor of final TIMI flow and survival : , 10.1160/th10-04-0246
  24. Vlaar Pieter J, Svilaas Tone, van der Horst Iwan C, Diercks Gilles FH, Fokkema Marieke L, de Smet Bart JGL, van den Heuvel Ad FM, Anthonio Rutger L, Jessurun Gillian A, Tan Eng-Shiong, Suurmeijer Albert JH, Zijlstra Felix, Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study, 10.1016/s0140-6736(08)60833-8
  25. , Wijns W., Kolh P., Danchin N., Di Mario C., Falk V., Folliguet T., Garg S., Huber K., James S., Knuuti J., Lopez-Sendon J., Marco J., Menicanti L., Ostojic M., Piepoli M. F., Pirlet C., Pomar J. L., Reifart N., Ribichini F. L., Schalij M. J., Sergeant P., Serruys P. W., Silber S., Sousa Uva M., Taggart D., Vahanian A., Auricchio A., Bax J., Ceconi C., Dean V., Filippatos G., Funck-Brentano C., Hobbs R., Kearney P., McDonagh T., Popescu B. A., Reiner Z., Sechtem U., Sirnes P. A., Tendera M., Vardas P. E., Widimsky P., Kolh P., Alfieri O., Dunning J., Elia S., Kappetein P., Lockowandt U., Sarris G., Vouhe P., Kearney P., von Segesser L., Agewall S., Aladashvili A., Alexopoulos D., Antunes M. J., Atalar E., Brutel de la Riviere A., Doganov A., Eha J., Fajadet J., Ferreira R., Garot J., Halcox J., Hasin Y., Janssens S., Kervinen K., Laufer G., Legrand V., Nashef S. A. M., Neumann F.-J., Niemela K., Nihoyannopoulos P., Noc M., Piek J. J., Pirk J., Rozenman Y., Sabate M., Starc R., Thielmann M., Wheatley D. J., Windecker S., Zembala M., , , , , Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 10.1093/eurheartj/ehq277
  26. Stone Gregg W., Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction : The INFUSE-AMI Randomized Trial, 10.1001/jama.2012.421
  27. Georgiadou Panagiota, Iliodromitis Efstathios K., Kolokathis Fotios, Varounis Christos, Gizas Vassilis, Mavroidis Manolis, Capetanaki Yassemi, Boudoulas Harisios, Kremastinos Dimitrios T., Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study, 10.1111/j.1365-2362.2010.02257.x
  28. Mazzone Annamaria, Parri Maria Serena, Giannessi Daniela, Ravani Marcello, Vaghetti Marco, Altieri Paola, Casalino Laura, Maltinti Maristella, Balbi Manrico, Barsotti Antonio, Berti Sergio, Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI : a prospective clinical study, 10.1097/mca.0b013e3283441d0b
  29. de Kleijn D. P. V., Moll F. L., Hellings W. E., Ozsarlak-Sozer G., de Bruin P., Doevendans P. A., Vink A., Catanzariti L. M., Schoneveld A. H., Algra A., Daemen M. J., Biessen E. A., de Jager W., Zhang H., de Vries J.-P., Falk E., Lim S. K., van der Spek P. J., Sze S. K., Pasterkamp G., Local Atherosclerotic Plaques Are a Source of Prognostic Biomarkers for Adverse Cardiovascular Events, 10.1161/atvbaha.109.194944
  30. Tousoulis Dimitris, Siasos Gerasimos, Maniatis Konstantinos, Oikonomou Evangelos, Kioufis Stamatios, Zaromitidou Marina, Paraskevopoulos Thodoris, Michalea Stavroula, Kollia Christina, Miliou Antigoni, Kokkou Eleni, Papavassiliou Athanasios G., Stefanadis Christodoulos, Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease, 10.1016/j.ijcard.2012.05.001
  31. Momiyama Yukihiko, Ohmori Reiko, Fayad Zahi A., Kihara Teruyoshi, Tanaka Nobukiyo, Kato Ryuichi, Taniguchi Hiroaki, Nagata Masayoshi, Nakamura Haruo, Ohsuzu Fumitaka, Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis, 10.1016/j.atherosclerosis.2009.12.024
  32. Yan Xiaoxiang, Sano Motoaki, Lu Lin, Wang Wei, Zhang Qi, Zhang Ruiyan, Wang Lingjie, Chen Qiujing, Fukuda Keiichi, Shen Weifeng, Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus, 10.1186/1475-2840-9-70
  33. Grion Cintia M. C., Cardoso Lucienne T. Q., Perazolo Tatianna F., Garcia Alexandre S., Barbosa Décio S., Morimoto Helena Kaminami, Matsuo Tiemi, Carrilho Alexandre J. F., Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients, 10.1111/j.1365-2362.2010.02269.x
  34. Hara Tetsuya, Ishida Tatsuro, Kojima Yoko, Tanaka Hanayo, Yasuda Tomoyuki, Shinohara Masakazu, Toh Ryuji, Hirata Ken-ichi, Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo, 10.1194/jlr.m008417
  35. Henning María F., Herlax Vanesa, Bakás Laura, Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect, 10.1177/1753425910370709
  36. Walters D. L., Ray M. J., Wood P., Perrin E. J., Bett J. H. N., Aroney C. N., High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention, 10.1111/j.1365-2362.2009.02237.x
  37. Layland Jamie, Ray Michael J, Siresena Tilak, Walters Darren L, Increased expression of monocyte tissue factor and soluble CD40 ligand at mid-term follow-up following percutaneous coronary intervention : , 10.1097/mbc.0b013e3283442ccd
  38. Ray Michael J., Calabro Lorenzo J., Sirisena Tilak, Crawford Scott A., Crawford Ross W., Walters Darren L., Pre-operative platelet-bound CD40 ligand is probably associated with peri-operative cardiac events in hip and knee arthroplasty : PLATELET CD40 LIGAND IS PROBABLY ASSOCIATED WITH CARDIAC EVENTS, 10.1111/j.1365-2362.2010.02289.x
  39. Mehran Roxana, Pocock Stuart, Nikolsky Eugenia, Dangas George D., Clayton Tim, Claessen Bimmer E., Caixeta Adriano, Feit Frederick, Manoukian Steven V., White Harvey, Bertrand Michel, Ohman E. Magnus, Parise Helen, Lansky Alexandra J., Lincoff A. Michael, Stone Gregg W., Impact of Bleeding on Mortality After Percutaneous Coronary Intervention, 10.1016/j.jcin.2011.02.011
  40. Wiviott Stephen D., Braunwald Eugene, McCabe Carolyn H., Montalescot Gilles, Ruzyllo Witold, Gottlieb Shmuel, Neumann Franz-Joseph, Ardissino Diego, De Servi Stefano, Murphy Sabina A., Riesmeyer Jeffrey, Weerakkody Govinda, Gibson C. Michael, Antman Elliott M., Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, 10.1056/nejmoa0706482
  41. Wallentin Lars, Becker Richard C., Budaj Andrzej, Cannon Christopher P., Emanuelsson Håkan, Held Claes, Horrow Jay, Husted Steen, James Stefan, Katus Hugo, Mahaffey Kenneth W., Scirica Benjamin M., Skene Allan, Steg Philippe Gabriel, Storey Robert F., Harrington Robert A., Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes, 10.1056/nejmoa0904327
  42. Yilmaz Yusuf, Eren Fatih, Yonal Oya, Kurt Ramazan, Aktas Bilge, Celikel Cigdem Ataizi, Ozdogan Osman, Imeryuz Nese, Kalayci Cem, Avsar Erol, Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease : FIBROBLAST GROWTH FACTOR 21 IN NAFLD, 10.1111/j.1365-2362.2010.02338.x
  43. Li Huating, Fang Qichen, Gao Fei, Fan Jia, Zhou Jian, Wang Xiaoying, Zhang Huizhen, Pan Xiaoping, Bao Yuqian, Xiang Kunsan, Xu Aimin, Jia Weiping, Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride, 10.1016/j.jhep.2010.05.018
  44. Yan Hongmei, Xia Mingfeng, Chang Xinxia, Xu Qiong, Bian Hua, Zeng Mengsu, Rao Shengxiang, Yao Xiuzhong, Tu Yinfang, Jia Weiping, Gao Xin, Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study, 10.1371/journal.pone.0024895
  45. Adlbrecht Christopher, Hülsmann Martin, Gwechenberger Marianne, Graf Senta, Wiesbauer Franz, Strunk Guido, Khazen Cesar, Brodnjak Isabella, Neuhold Stephanie, Binder Thomas, Maurer Gerald, Pacher Richard, Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long-term outcome : ASSOCIATION OF CARDIAC RESYNCHRONIZATION ELECTRICAL OPTIMIZATION WITH IMPROVED CLINICAL LONG-TERM OUTCOME, 10.1111/j.1365-2362.2010.02311.x
  46. Adlbrecht C., Hülsmann M., Gwechenberger M., Strunk G., Khazen C., Wiesbauer F., Elhenicky M., Neuhold S., Binder T., Maurer G., Lang I. M., Pacher R., Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment : DEVICE THERAPY AND MEDICAL TREATMENT IN CHF, 10.1111/j.1365-2362.2009.02217.x
  47. Ellenbogen K. A., Gold M. R., Meyer T. E., Fernndez Lozano I., Mittal S., Waggoner A. D., Lemke B., Singh J. P., Spinale F. G., Van Eyk J. E., Whitehill J., Weiner S., Bedi M., Rapkin J., Stein K. M., Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchronization Therapy, 10.1161/circulationaha.110.992552
  48. Shanmugam N., Borgulya G., Anderson L., Letter by Shanmugam et al Regarding Article, "Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchronization Therapy", 10.1161/circulationaha.110.013474
  49. Sawhney Navinder S., Waggoner Alan D., Garhwal Sanjeev, Chawla Mohit K., Osborn Judy, Faddis Mitchell N., Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy, 10.1016/j.hrthm.2004.07.006
  50. , McMurray J. J. V., Adamopoulos S., Anker S. D., Auricchio A., Bohm M., Dickstein K., Falk V., Filippatos G., Fonseca C., Gomez-Sanchez M. A., Jaarsma T., Kober L., Lip G. Y. H., Maggioni A. P., Parkhomenko A., Pieske B. M., Popescu B. A., Ronnevik P. K., Rutten F. H., Schwitter J., Seferovic P., Stepinska J., Trindade P. T., Voors A. A., Zannad F., Zeiher A., Bax J. J., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck-Brentano C., Hasdai D., Hoes A., Kirchhof P., Knuuti J., Kolh P., McDonagh T., Moulin C., Popescu B. A., Reiner Z., Sechtem U., Sirnes P. A., Tendera M., Torbicki A., Vahanian A., Windecker S., McDonagh T., Sechtem U., Bonet L. A., Avraamides P., Ben Lamin H. A., Brignole M., Coca A., Cowburn P., Dargie H., Elliott P., Flachskampf F. A., Guida G. F., Hardman S., Iung B., Merkely B., Mueller C., Nanas J. N., Nielsen O. W., Orn S., Parissis J. T., Ponikowski P., , , ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, 10.1093/eurheartj/ehs104
  51. Bouzas-Mosquera Alberto, Peteiro Jesús, Broullón Francisco J., Álvarez-García Nemesio, Méndez Elizabet, Pérez Alberto, Mosquera Victor X., Castro-Beiras Alfonso, Value of exercise echocardiography for predicting mortality in elderly patients : EXERCISE ECHO IN THE ELDERLY, 10.1111/j.1365-2362.2010.02365.x
  52. Peteiro Jesús, Bouzas-Mosquera Alberto, Estevez Rodrigo, Pazos Pablo, Piñeiro Miriam, Castro-Beiras Alfonso, Head-to-Head Comparison of Peak Supine Bicycle Exercise Echocardiography and Treadmill Exercise Echocardiography at Peak and at Post-Exercise for the Detection of Coronary Artery Disease, 10.1016/j.echo.2011.11.002
  53. Bernheim, Am Heart J, 25, 319 (2012)
  54. Rai Mridula, Baker William Leslie, Parker Matthew Wayne, Heller Gary Vashon, Meta-Analysis of Optimal Risk Stratification in Patients >65 Years of Age, 10.1016/j.amjcard.2012.05.048
  55. Schiza Sophia E., Mermigkis Charalampos, Panagiotis Panagou, Bouloukaki Izolde, Kallergis Eleftherios, Tzanakis Nikolaos, Tzortzaki Eleni, Vlachaki Eleni, Siafakas Nikolaos M., C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy : C-REACTIVE PROTEIN EVOLUTION DURING CPAP THERAPY, 10.1111/j.1365-2362.2010.02348.x
  56. Guo Yongzhong, Pan Lei, Ren Dunqiang, Xie Xiaomei, Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis, 10.1007/s11325-012-0722-2
  57. Mermigkis Charalampos, Mermigkis Demetrios, Varouchakis Georgios, Schiza Sophia, CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea—therapeutic difficulties and dilemmas, 10.1007/s11325-010-0476-7
  58. Kumor, Pneumonol Alergol Pol, 79, 173 (2011)
  59. Colish Jane, Walker Jonathan R., Elmayergi Nader, Almutairi Saleh, Alharbi Fawaz, Lytwyn Matthew, Francis Andrew, Bohonis Sheena, Zeglinski Matthew, Kirkpatrick Iain D.C., Sharma Sat, Jassal Davinder S., Obstructive Sleep Apnea, 10.1378/chest.11-0615
  60. Chang Kuo-Chu, Tseng Chuen-Den, Lu Shao-Chun, Liang Jin-Tung, Wu Ming-Shiou, Tsai Ming-Shian, Hsu Kwan-Lih, Effects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic rats : ACETYL-L-CARNITINE IMPROVES DIABETIC AORTAS, 10.1111/j.1365-2362.2010.02358.x
  61. Slatter D. A., Bolton C. H., Bailey A. J., The importance of lipid-derived malondialdehyde in diabetes mellitus, 10.1007/s001250051342
  62. Satomura Atsushi, Fujita Takayuki, Fuke Yoshinobu, Yanai Mitsuru, Kumasaka Kazunari, Takayama Eiichi, Hamada Hiroaki, Maruyama Toshiharu, Nakayama Tomohiro, Relationship between oligomer and functional serum mannose-binding lectin in chronic renal failure : MANNOSE-BINDING LECTIN IN CHRONIC RENAL FAILURE, 10.1111/j.1365-2362.2010.02325.x
  63. Satomura Atsushi, Fujita Takayuki, Yanai Mitsuru, Kumasaka Kazunari, Uehara Yuki, Okada Kazuyoshi, Fuke Yoshinobu, Nakayama Tomohiro, Functional Mannose-Binding Lectin Levels in Patients with End-Stage Renal Disease on Maintenance Hemodialysis, 10.1159/000334601
  64. Summerfield J.A., Ryder S., Sumiya M., Thursz M., Gorchein A., Monteil M.A., Turner M.W., Mannose binding protein gene mutations associated with unusual and severe infections in adults, 10.1016/s0140-6736(95)90009-8
  65. Frøkjaer Jens B., Søfteland Eirik, Graversen Carina, Dimcevski Georg, Drewes Asbjørn M., Effect of acute hyperglycaemia on sensory processing in diabetic autonomic neuropathy : SENSORY PROCESSING IN ACUTE HYPERGLYCAEMIA, 10.1111/j.1365-2362.2010.02335.x
  66. Frøkjaerl Jens Brøndum, Egsgaardl Line Lindhardt, Graversenl Carina, Søftelandl Eirik, Dimcevskil Georg, Blauenfeldtl Rolf Ankerlund, Drewesl Asbjørn Mohr, Gastrointestinal symptoms in type-1 diabetes: Is it all about brain plasticity?, 10.1016/j.ejpain.2010.08.004
  67. Frøkjaer, Diabetes Care (2012)
  68. Lee Ting-I., Kao Yu-Hsun, Chen Yao-Chang, Pan Nan-Hung, Chen Yi-Jen, Oxidative stress and inflammation modulate peroxisome proliferator-activated receptors with regional discrepancy in diabetic heart : PPAR ISOFORMS IN DIABETIC CARDIOMYOCYTES, 10.1111/j.1365-2362.2010.02318.x
  69. Lee Ting-I, Kao Yu-Hsun, Chen Yao-Chang, Pan Nan-Hung, Lin Yung-Kuo, Chen Yi-Jen, Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes, 10.1042/cs20100529
  70. Cheng Chen-Chuan, Pan Nan-Hung, Chen Yao-Chang, Yeh Hung-I, Lin Cheng-I, Chen Shih-Ann, Chen Yi-Jen, Atherosclerosis modulates the electrophysiological effects of a peroxisome proliferator-activated receptor-gamma activator on pulmonary veins, 10.1016/j.ijcard.2010.05.065
  71. Lee, Int J Cardiol (2012)
  72. Skelton William P., Pi Guillermo, Lenz Anne, Sun Ying, Vesely David L., Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells : INHIBITION OF PROLIFERATION OF CANCER CELLS, 10.1111/j.1365-2362.2010.02309.x
  73. Serafino Annalucia, Moroni Noemi, Psaila Rossana, Zonfrillo Manuela, Andreola Federica, Wannenes Francesca, Mercuri Luana, Rasi Guido, Pierimarchi Pasquale, Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: Evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling, 10.1016/j.bbadis.2012.02.016
  74. Vesely, In Vivo, 21, 445 (2007)
  75. Skelton, Anticancer Res, 31, 395 (2011)
  76. Pi, Cancer Ther, 8, 44 (2011)
  77. Chung Yuan-Chiang, Lin Chih-Cheng, Chou Chih-Chung, Hsu Chih-Ping, The effect of Longan seed polyphenols on colorectal carcinoma cells : EFFECT OF LSP ON COLON CANCER CELLS, 10.1111/j.1365-2362.2010.02322.x
  78. Chung, World J Exp Med (2012)
  79. Stärkel Peter, De Saeger Christine, Strain Alastair J., Leclercq Isabelle, Horsmans Yves, NFκB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease : NFκB IN HUMAN END-STAGE CIRRHOSIS, 10.1111/j.1365-2362.2010.02295.x
  80. Leclercq Sophie, Cani Patrice D., Neyrinck Audrey M., Stärkel Peter, Jamar François, Mikolajczak Moïra, Delzenne Nathalie M., de Timary Philippe, Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects, 10.1016/j.bbi.2012.04.001
  81. Tamura Ryo, Kanda Tatsuo, Imazeki Fumio, Wu Shuang, Nakamoto Shingo, Tanaka Takeshi, Arai Makoto, Fujiwara Keiichi, Saito Kengo, Roger Thierry, Wakita Takaji, Shirasawa Hiroshi, Yokosuka Osamu, Hepatitis C Virus Nonstructural 5A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4, 10.1093/infdis/jir381
  82. Berzsenyi M. D., Roberts S. K., Preiss S., Woollard D. J., Beard M. R., Skinner N. A., Bowden D. S., Visvanathan K., Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection : TLR & hepatic inflammation in HCV & HCV/HIV, 10.1111/j.1365-2893.2010.01390.x
  83. Hung Ming-Yow, Hsu Kuang-Hung, Hung Ming-Jui, Cheng Chi-Wen, Cherng Wen-Jin, Interactions among gender, age, hypertension and C-reactive protein in coronary vasospasm : INTERACTIONS AMONG FACTORS FOR SPASM, 10.1111/j.1365-2362.2010.02360.x
  84. Hung Ming-Jui, Cherng Wen-Jin, Hung Ming-Yow, Kuo Li-Tang, Cheng Chi-Wen, Wang Chao-Hung, Yang Ning-I, Liao James K., Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina, 10.1016/j.atherosclerosis.2012.01.001
  85. Wang Shu, Reed Debra B., Goli Srikanth, Goswami Debalina, Blood leptin and C-reactive protein provide more sensitive assessment than blood lipids and other inflammatory biomarkers in overweight university students, 10.1016/j.nutres.2011.07.006
  86. Kawamoto Ryuichi, Tabara Yasuharu, Kohara Katsuhiko, Miki Tetsuro, Kusunoki Tomo, Takayama Shuzo, Abe Masanori, Katoh Tateaki, Ohtsuka Nobuyuki, Association between fasting plasma glucose and high-sensitivity C-reactive protein: gender differences in a Japanese community-dwelling population, 10.1186/1475-2840-10-51
  87. Kawano Hiroaki, Node Koichi, The role of vascular failure in coronary artery spasm, 10.1016/j.jjcc.2010.08.007
  88. Pascual Gemma, Rodríguez Marta, Gómez-Gil Verónica, Trejo Cynthia, Buján Julia, Bellón Juan Manvel, Active matrix metalloproteinase-2 upregulation in the abdominal skin of patients with direct inguinal hernia : MMP-2 UPREGULATION IN DIRECT INGUINAL HERNIA, 10.1111/j.1365-2362.2010.02364.x
  89. Klinge U., Si Z.Y., Zheng H., Schumpelick V., Bhardwaj R.S., Klosterhalfen B., Abnormal Collagen I to III Distribution in the Skin of Patients with Incisional Hernia, 10.1159/000008740
  90. Rosch Raphael, Klinge Uwe, Si Zhongyi, Junge Karsten, Klosterhalfen Bernd, Schumpelick Volker, A role for the collagen I/III and MMP-1/-13 genes in primary inguinal hernia?, 10.1186/1471-2350-3-2
  91. BELLON J. M., BUJAN J., HONDUVILLA N. G., JURADO F., GIMENO M. J., TURNAY J., OLMO N., LIZARBE M. A., Study of biochemical substrate and role of metalloproteinases in fascia transversalis from hernial processes, 10.1046/j.1365-2362.1997.1400686.x
  92. Bellón Juan M., Bajo Ana, Ga-Honduvilla Natalio, Gimeno María J., Pascual Gemma, Guerrero Ana, Buján Julia, Fibroblasts From the Transversalis Fascia of Young Patients With Direct Inguinal Hernias Show Constitutive MMP-2 Overexpression : , 10.1097/00000658-200102000-00020
  93. Antoniou George A., Tentes Ioannis K., Antoniou Stavros A., Simopoulos Constantinos, Lazarides Miltos K., Matrix Metalloproteinase Imbalance in Inguinal Hernia Formation, 10.3109/08941939.2011.558610
  94. Phrommintikul Arintaya, Sivasinprasasn Sivaporn, Lailerd Narissara, Chattipakorn Siriporn, Kuanprasert Srun, Chattipakorn Nipon, Plasma urocortin in acute myocardial infarction patients : UROCORTIN IN ACUTE MYOCARDIAL INFARCTION, 10.1111/j.1365-2362.2010.02343.x
  95. Calderón-Sánchez Eva María, Ruiz-Hurtado Gema, Smani Tarik, Delgado Carmen, Benitah Jean Pierre, Gómez Ana María, Ordóñez Antonio, Cardioprotective action of urocortin in postconditioning involves recovery of intracellular calcium handling, 10.1016/j.ceca.2011.05.010
  96. Takatani-Nakase Tomoka, Takahashi Koichi, Cardioprotective activity of urocortin by preventing caspase-independent, non-apoptotic death in cultured neonatal rat cardiomyocytes exposed to ischemia, 10.1016/j.bbrc.2010.10.001
  97. Barry S. P., Lawrence K. M., McCormick J., Soond S. M., Hubank M., Eaton S., Sivarajah A., Scarabelli T. M., Knight R. A., Thiemermann C., Latchman D. S., Townsend P. A., Stephanou A., New targets of urocortin-mediated cardioprotection, 10.1677/jme-09-0148
  98. Aigner E., Hinz C., Steiner K., Rossmann B., Pfleger J., Hohla F., Steger B., Stadlmayr A., Patsch W., Datz C., Iron stores, liver transaminase levels and metabolic risk in healthy teenagers, 10.1111/j.1365-2362.2009.02238.x
  99. Kowdley Kris V., Belt Patricia, Wilson Laura A., Yeh Matthew M., Neuschwander-Tetri Brent A., Chalasani Naga, Sanyal Arun J., Nelson James E., , Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease, 10.1002/hep.24706
  100. Weismüller Tobias J., Kirchner Gabriele I., Scherer Marcus N., Negm Ahmed A., Schnitzbauer Andreas A., Lehner Frank, Klempnauer Jürgen, Schlitt Hans J., Manns Michael P., Strassburg Christian P., Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival, 10.1002/hep.24635
  101. Houschyar Khosrow S, Lüdtke Rainer, Dobos Gustav J, Kalus Ulrich, Broecker-Preuss Martina, Rampp Thomas, Brinkhaus Benno, Michalsen Andreas, Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial, 10.1186/1741-7015-10-54
  102. Aigner Elmar, Strasser Michael, Haufe Heike, Sonnweber Thomas, Hohla Florian, Stadlmayr Andreas, Solioz Marc, Tilg Herbert, Patsch Wolfgang, Weiss Guenter, Stickel Felix, Datz Christian, A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease, 10.1038/ajg.2010.170
  103. Aigner Elmar, Felder Thomas K., Oberkofler Hannes, Hahne Penelope, Auer Simon, Soyal Selma, Stadlmayr Andreas, Schwenoha Karin, Pirich Christian, Hengster Paul, Datz Christian, Patsch Wolfgang, Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations, 10.1016/j.jnutbio.2012.02.017
Bibliographic reference Adlbrecht, Christopher ; Aigner, Elmar ; Bellón, Juan M. ; Bouloukaki, Izolde ; Bouzas-Mosquera, Alberto ; et. al. Research update for articles published in EJCI in 2010. In: European Journal of Clinical Investigation, Vol. 42, no. 11, p. 1149-1164 (2012)
Permanent URL http://hdl.handle.net/2078.1/161147